Andrew Rosenberg
🏛️ Revolving DoorFormer Government Positions:
Leg Asst, Kennedy; Leg Aide, Senate HELP Comm
Leg. Assistant, Senator Edward Kennedy; Leg. Aide Senate HELP Committee
;
🤖
AI Overview
Andrew Rosenberg has appeared in 823 federal lobbying filings at Thorn Run Partners, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 20 policy areas.
823
Total Filings
1
Firms
50
Clients
20
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 78 | 13 |
| 2019 | 74 | 20 |
| 2020 | 89 | 16 |
| 2021 | 133 | 23 |
| 2022 | 146 | 21 |
| 2023 | 120 | 19 |
| 2024 | 89 | 19 |
| 2025 | 94 | 20 |
Firms
Thorn Run Partners823 filings
Top Clients
Novartis Corporation65 filings
Amplifon USA60 filings
Medical Device Manufacturers Association38 filings
Steris Corporation37 filings
Exelixis35 filings
Glaukos Corporation34 filings
Continuing Medical Education Coalition32 filings
Republic Airlines, INC.30 filings
Institute for Gene Therapies25 filings
Eli Lilly and Company25 filings
Glaxosmithkline LLC23 filings
National Home Infusion Association22 filings
Harmony Biosciences19 filings
Association of Air Medical Services16 filings
Sourceamerica14 filings
Avis Budget Car Rental, LLC14 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Foreign Governments Are Lobbying Congress
1,000+ foreign entities from 50+ countries lobby the US government.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.